{"entity":{"type":"insider","cik":"0001834424","url":"/insider/0001834424","json_url":"/insider/0001834424.json","name":"Stimart Tryn","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2020-12-17","last":"2021-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Stimart Tryn","source":"filing","n_filings":2,"first_seen":"2020-12-17","last_seen":"2021-06-10"}],"transactions":[{"id":5276470,"accession":"0000899243-21-022989","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-022989","line_url":"/filing/0000899243-21-022989#line-1","is_derivative":false,"issuer_cik":"0001703057","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001703057","owner_cik":"0001834424","owner_name":"Stimart Tryn","owner_url":"/insider/0001834424","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":25500000.0,"total_display":"25,500,000.00","shares_owned_after":250.0,"shares_owned_after_display":"250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-10","scope":"insider"},{"id":2385578,"accession":"0000899243-20-034339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034339","line_url":"/filing/0000899243-20-034339#line-2","is_derivative":false,"issuer_cik":"0001703057","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001703057","owner_cik":"0001834424","owner_name":"Stimart Tryn","owner_url":"/insider/0001834424","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","shares_owned_after":250.0,"shares_owned_after_display":"250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":2385574,"accession":"0000899243-20-034339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-034339","line_url":"/filing/0000899243-20-034339#line-1","is_derivative":false,"issuer_cik":"0001703057","issuer_name":"AbCellera Biologics Inc.","issuer_ticker":"ABCL","issuer_name_source":null,"issuer_url":"/issuer/0001703057","owner_cik":"0001834424","owner_name":"Stimart Tryn","owner_url":"/insider/0001834424","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","shares_owned_after":250.0,"shares_owned_after_display":"250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001703057","name":"AbCellera Biologics Inc.","url":"/issuer/0001703057","role":"Officer (Chief Legal Officer)","n_filings":2,"first_seen":"2020-12-17","last_seen":"2021-06-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001834424","retrieved_at":"2026-08-21T03:44:34+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}